Journals / SSK Tepecik Eğitim Hastanesi Dergisi / 2003 / Cilt: 13 - Sayı: 2

C-reactive protein in predicting congestive heart failure occurrence in acute myocardial infarction

C-reaktif protein'in akut miyokard infarktüs'ünde konjestif kalp yetmezliği gelişmesindeki belirleyici rolü

Pages
75–79
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CRP levels can be used in determining the high risk patients in AMI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: High C - reactive protein (CRP) levels have been associated with larger infarct area, higher complication and mortality rates in patients with acute myocardial infarction (AMI).
📊
Key Findings & Data:Results: CHF was found clinically in 26.9 % of patients.
💡
Conclusion & Impact:CRP levels can be used in determining the high risk patients in AMI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Akut hastalık · Ekokardiyografi · Miyokard enfarktüsü

Abstract

Aim: High C - reactive protein (CRP) levels have been associated with larger infarct area, higher complication and mortality rates in patients with acute myocardial infarction (AMI). In this study, our aim was to evaluate the relationship between CRP levels and the occurrence of congestive heart failure (CHF) during early phases of AMI. Methods: Seventy eight patients diagnosed as ST segment elevated AMI, were evaluated to determine the predictive role of CRP in CHF occurrence. The first obtained blood sample on admission to Coronary CareUnit (CCU) was used for CRP level determination. CHF was evaluated by Killip classification clinically and by Simson method echocardiographically. Results: CHF was found clinically in 26.9 % of patients. The comparision of CRP levels in the patient groups with and without CHF, indicated that higher levels were determined in CHF group (p < 0.01). The patients were grouped in three subgroups according to their echocardiographically determined left ventricular ejection fraction (EF) values. CRP levels of the group with EF< % 39 was higher than the other groups (p < 0.01). A negative correlation between CRP and EF was obtained (p< 0.01). Similarly a positive correlation was shown between CRP and Killip groups (p<0.05). Conclusions: In this study, it was shown that CRP values obtained at admission to CCU were strongly related with CHF occurence in AMI. CRP levels can be used in determining the high risk patients in AMI.

Özet

Amaç: Yüksek C- reaktif protein (CRP) düzeylerinin akut miyokard infarktüsünde (AMİ) infarkt alanının genişliği, komplikasyon ve mortalite oranlarında artış ile ilişkili olduğu gösterilmiştir. Çalışmamızda AMİ'nde CRP yüksekliğinin konjestif kalp yetmezliğinin (KKY) ortaya çıkışı ile ilişkisi araştırılmıştır. Yöntem: Çalışmamızda ST segment yükselmeli AMİ tanısı alan 78 olgu, Koroner Bakım Ünitesinde (KBÜ) alınan ilk kan örneklerinden ölçülen CRP değerlerinin KKY gelişmesi ile olan ilişkisi açısından değerlendirilmiştir. KKY gelişmesinin takibinde, klinik olarak Killip sınıflaması ve ekokardiyografik olarak Simson yöntemi kullanılmıştır. Bulgular: Olguların %26.9'unda AMİ'ne ikincil kalp yetmezliği klinik olarak değişik derecelerde ortaya çıkmıştır. KKY gelişen ve gelişmeyen olgular karşılaştırıldığında, CRP değerleri KKY gelişenlerde anlamlı derecede yüksek bulunmuştur (p % 50 olan gruplara göre anlamlı yüksek olduğu saptanmıştır (p < 0.01). Çalışmamızda CRP düzeyleri ile EF arasında p < 0.01 düzeyinde negatif korelasyon, Killip grupları arasında ise p < 0.05 düzeyinde pozitif korelasyon tesbit edilmiştir . Sonuç: AMİ'de KBÜ'de alınan ilk kan örneklerinden çalışılan CRP değerlerinin yüksekliğinin, AMİ'ünün en önemli komplikasyonlarmdan biri olan KKY ile ilişkili olduğu gösterilmiştir. Yüksek riskli hastaların tespitinde CRP değerlerinden yararlanılabileceği sonucuna varılmıştır.

🔖

Cite This Article

ÖZBAKKALOĞLU, M., DEMİRCİ, C., AKTEPE, G., ÇAKMAK, T., GÜÇLÜ, Y., LATİF, Ö. (2003). C-reactive protein in predicting congestive heart failure occurrence in acute myocardial infarction. SSK Tepecik Eğitim Hastanesi Dergisi, Cilt: 13 - Sayı: 2, 75–79. https://ajindex.com/articles/312856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Maron DJ, Ridker P, Pearson T. Dyslipidemia, other risk factor and the prevention of coronary heart disease. In: Fuster V, Alexander W, O'Rourke R, editors. Hurst's The Heart. 10th ed. New York: Me GrawHill;2001.p. 1148-9
  2. Kimura K, Kosuge M, Ishikawa T, Shimizu M, Endo T, Hongo Y, et al. Relationship between myocardial damage and C - reactive protein levels immediately after onset of acute myocardial infarction. Jpn Circ J 2001;65: 67-70
  3. Haverkate F, Thompson SG, Pyke SD. Production of C - reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6
  4. Tomoda H, Aoki N. Prognostic value of C - reactive protein levels within six hours after the onset acute myocardial infarction. Am Heart J 2000; 140:324-8
  5. De Beer FC, Hind C, Fox KM. Measurement of serum C - reactive protein concentration in myocardial ischemia and infarction. Br Heart J 1982;47:239-43
  6. Auer J, Berent R, Lassnig E, Eber B. C - reactive protein and coronary artery disease. Jpn Heart J 2002;43:607-19
  7. Marciniak A, Gierblinski I, Stefanski R, Lapinski M, Gaciong Z, Barthlomiejczyk I, et al. Predictive value of plasma interleukin 1, interleukin 6, interleukin 8 and C - reactive protein in patients with myocardial infarction. Pol Arch Med 2003;109:15-22
  8. Tommasi S, Carluccio E, Bentivoglio M. C - reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. AmJCardiol 1999;83:1595-9
  9. Nikfardjam M, Mullner M, Screiber W, Gelson K. The association between C - reactive protein on admission and mortality in patients with acute myocardial infarction. Jin tern Med 2000;247:341 -5
  10. Zebrack JS, Anderson J, Maycock CA, Home B, Muhlestein J. Usefulness of high sensitivity C - reactive protein in predicting long - term risk of death or acute myocardial infarction in patients with stable and unstable angina pectoris or acute myocardial infarction. Am J Cardiol 2002;89:145-9
  11. De Sutter J, De Buyzere M, Van de Wiele C, Voet J, De Pauw M, Dierckx R, et al. Fibrionogen and C -reactive protein on admission as markers of final infarct size after pimary angioplasty for acute myocardial infarction. Atherosclerosis 2001;157:189-96
  12. Pietila KO, Harmoinen Ap, Jokinity J. Serum C - reactive protein concentration in of acute myocardial infarction and its relationship to mortality during 24 months follow - up in patients under thrombolytic treatment. Eur Heart J 1996;17:1345-9
  13. Emanue